Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli; Azita H. Talasaz; Farid Rashidi; Hooman Bakhshandeh; Farnaz Rafiee; Parisa Rezaeifar; Elahe Baghizadeh; Samira Matin; Sepehr Jamalkhani; Ouria Tahamtan; Babak Sharif-Kashani; Mohammad Taghi Beigmohammadi; Mohsen Farrokhpour; Seyed Hashem Sezavar; Pooya Payandemehr; Ali Dabbagh; Keivan Gohari Moghadam; Hossein Khalili; Mahdi Yadollahzadeh; Taghi Riahi; Atefeh Abedini; Somayeh Lookzadeh; Hamid Rahmani; Elnaz Zoghi; Keyhan Mohammadi; Parham Sadeghipour; Homa Abri; Sanaz Hariri Tabrizi; Seyed Masoud Mousavian; Shaghayegh Shahmirzaei; Ahmad Amin; Bahram Mohebbi; Seyed Ehsan Parhizgar; Rasoul Aliannejad; Vahid Eslami; Alireza Kashefizadeh; Paul P. Dobesh; Hessam Kakavand; Seyed Hossein Hosseini; Shadi Shafaghi; Samrand Fattah Ghazi; Atabak Najafi; David Jiménez; Aakriti Gupta; Mahesh V. Madhavan; Sanjum S. Sethi; Sahil A. Parikh; Manuel Monréal; Naser Hadavand; Alireza Hajighasemi; Majid Maleki; Saeed Sadeghian; Gregory Piazza; Ajay J. Kirtane; Benjamín Van Tassell; Gregg W. Stone; Professor Gregory Lip; Harlan M. Krumholz; Samuel Z. Goldhaber; Parham Sadeghipour

doi:10.1055/a-1485-2372

Shared by

Professor Gregory Lip

University of Liverpool

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Article 2021 en

Authors

BB
Behnood Bikdeli
AT
Azita H. Talasaz
FR
Farid Rashidi

Abstract

1 min read

Intermediate-dose compared with standard-dose prophylactic anticoagulation did not reduce a composite of death, treatment with ECMO, or venous or arterial thrombosis at 90-day follow-up.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial

Azita H. Talasaz, Parham Sadeghipour, Hooman Bakhshandeh, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somaye Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Mohsen Farrokhpour, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ouria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hamid Rahmani, Seyed Hossein Hosseini, Seyed Masoud Mousavian, Homa Abri, Parham Sadeghipour, Elahe Baghizadeh, Farnaz Rafiee, Sepehr Jamalkhani, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mahshid Soleimanzadeh, Maryam Aghakouchakzadeh, Vahid Eslami, Pooya Payandemehr, Hossein Khalili, Hamed Talakoob, Taranom Tojari, Shadi Shafaghi, Sanaz Hariri Tabrizi, Hessam Kakavand, Alireza Kashefizadeh, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V. Madhavan, Sanjum S. Sethi, Sahil A. Parikh, Manuel Monréal, Naser Hadavand, Alireza Hajighasemi, Khalil Ansarin, Majid Maleki, Saeed Sadeghian, Stefano Barco, Bob Siegerink, Erica S. Spatz, Gregory Piazza, Ajay J. Kirtane, Benjamín Van Tassell, Professor Gregory Lip, Frederikus A. Klok, Samuel Z. Goldhaber, Gregg W. Stone, Harlan M. Krumholz, Behnood Bikdeli

Article2021

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

David M. Smadja, David M. Smadja, Guillaume Bonnet, Guillaume Bonnet, Nicolas Gendron, Nicolas Gendron, Orianne Weizman, Orianne Weizman, Lina Khider, Lina Khider, Antonin Trimaille, Antonin Trimaille, Tristan Mirault, Tristan Mirault, Charles Fauvel, Charles Fauvel, Jean‐Luc Diehl, Jean‐Luc Diehl, Delphine Mika, Delphine Mika, Aurélien Philippe,

Article2023

Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial

Azita H. Talasaz, Parham Sadeghipour, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somayeh Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Gregory Piazza, Mohsen Farrokhpour, Hooman Bakhshandeh, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ouria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hossein Mirshojaeian Hosseini,

Article2019

P5588Early versus delayed oral anticoagulation in patients with acute pulmonary embolism: determinants and outcome

Cecilia Becattini, Ludovica Anna Cimini, Mareike Lankeit, Piotr Pruszczyk, Simone Vanni, Peiman Nazerian, Marta Kozłowska, C Casula, Alessandra Vinci, M Ottaviani, Alessandro Coppa, Maria Cristina Vedovati, Giancarlo Agnelli

Article2023

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Paulus Kirchhof, Tobias Toennis, Andreas Goette, A. John Camm, Hans‐Christoph Diener, Nina Becher, Emanuele Bertaglia, Carina Blomström Lundqvist, Martin Borlich, Axel Brandes, Nuno Cabanelas, Melanie Calvert, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Joris R. de Groot, Wolfgang Dichtl, Borys B. Kravchuk, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Douglas S. Scherr,